Related content

ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine

By          

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 182-188

Spandidos Publications

Access to resources Recommend Favorite

Effect of the dual phosphatidylinositol 3kinase/mammalian target of rapamycin inhibitor NVPBEZ235 against human Merkel cell carcinoma MKL1 cells

By          

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3663-3667

Spandidos Publications

Access to resources Recommend Favorite

Induction of apoptosis and suppression of angiogenesis of hepatocellular carcinoma by HS-159, a novel phosphatidylinositol 3-kinase inhibitor

By              

International Journal of Oncology, Vol. 43, Iss. 1, 2013-01 ,pp. : 201-209

Spandidos Publications

Access to resources Recommend Favorite

A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies

By Ma Cynthia   Mandrekar Sumithra   Alberts Steven   Croghan Gary   Jatoi Aminah   Reid Joel   Hanson Lorelei   Bruzek Laura   Tan Angelina   Pitot Henry   Erlichman Charles   Wright John   Adjei Alex  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 2, 2007-02 ,pp. : 207-215

Springer Publishing Company

Access to resources Recommend Favorite

A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells

By Bektas Meryem   Johnson Stewart   Poe William   Bigner Darell   Friedman Henry  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 1053-1058

Springer Publishing Company

Access to resources Recommend Favorite